Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (MBM; CheckMate 204) Tawbi, H., Forsyth, P., Hodi, F., Lao, C., Moschos, S., Hamid, O., Atkins, M. B., Lewis, K., Thomas, R. P., Glaspy, J. A., Jang, S., Algazi, A., Khushalani, N. I., Postow, M. A., Pavlick, A. C., Ernstoff, M., Reardon, D. A., Balogh, A., Rizzo, J., Margolin, K. NATURE PUBLISHING GROUP. 2019: 20

View details for Web of Science ID 000505173600055